List view / Grid view
30 May 2017 | By American College of Physicians
Stepping up to biologic therapy offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs...
30 May 2017 | By Quotient Clinical
Appointment supports Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions...
30 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration (FDA) approved the expanded use of Novartis’ Zykadia (ceritinib) to include patients with NSCLC...
26 May 2017 | By F.P.S. Food and Pharma Systems Srl
FPS has recently delivered a high containment Integrated systems for an Oncology plant in Bangalore...
26 May 2017 | By Niamh Marriott, Junior Editor
A trial led by a McMaster University respirology professor shows promising results for a new medicine for severe asthma patients.
26 May 2017 | By Niamh Marriott, Junior Editor
The FDA has granted Orphan Drug Designation for Abeona Therapeutics’s EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa...
25 May 2017 | By Niamh Marriott, Junior Editor
A pioneering medical technology firm has launched a unique manufacturing facility to extract collagen from jellyfish.
25 May 2017 | By Niamh Marriott, Junior Editor
The European Commission has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new formulation...
25 May 2017 | By Niamh Marriott, Junior Editor
The study assessed the efficacy of a drug candidate proposed by BenevolentAI’s artificial Intelligence technology for Motor Neuron Disease (MND)...
25 May 2017 | By Wickham Laboratories
Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods...
24 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker)...
24 May 2017 | By Niamh Marriott, Junior Editor
AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK treatments in Europe...
24 May 2017 | By Niamh Marriott, Junior Editor
A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to new research...
24 May 2017 | By Niamh Marriott, Junior Editor
In a new study, Uppsala University researchers have successfully measured 92 different proteins in millimetre-sized circles punched out of dried samples...
24 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved two new indications for Merck’s Keytruda (pembrolizumab), the company’s anti-PD-1 therapy, for bladder cancer...
